PATENT CLAIM ANALYSIS

Application Number: 16000670
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["424", "400000"]

Abstract:
Provided herein are long-acting, non-aqueous pharmaceutically acceptable compositions of active ingredients for subcutaneous injection, in particular analgesics such as buprenorphine.

Claim (Index 27):
The method of  claim 21 , wherein the blood concentration of the lipophilic active substance is greater than about 1 ng/ml for more than about 40, 50, 60, 70 or 80 hours following administration of the composition.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 94.0
- Lexical Diversity: 1.04545
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12855889', '14633545', '13193571', '14977680', '13754969']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6880396869697333
- 35 USC 102 Novelty (BERT): 0.517473189909737
- Combined Prediction Score: 0.6709830372637337
- Mean Citation Score: 197.940104
- Max Citation Score: 206.80139
- Similarity Product: 115.45830454010486

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test